PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsconduct disorder
MeSH D019955 - conduct disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D019958:Attention deficit and disruptive behavior disorders
34 Companies
1 Drug
$
Success rate
D019955: 
Conduct disorder
19 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Glenmark PharmaceuticalsLithium Lithium  2009-02-03   
MylanLithium Lithium  2002-06-27   
BayerLithium Lithane  1985-07-18   
PfizerLithium Lithium  1982-01-01   
Sun Pharmaceutical IndustriesLithium Lithium  2010-06-24   
Alembic PharmaceuticalsLithium Lithium  2009-01-12   
ApotexLithium Lithium  2004-11-22   
HeteroLithium Lithium  2009-09-25   
ANI PharmaceuticalsLithium Lithobid  1982-01-01   
Able LaboratoriesLithium Lithium  2001-09-27   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
50%
1/2
Phase 2
33%
1/3
Phase 3
100%
5/5
Approved: 2Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Lithium,
Lithium carbonate
JDS Pharmaceuticals
Lithium,
Lithium carbonate
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use